Back to Trades
Ho Carole
DirectorCIK 0001724605
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 5
- Buy transactions
- 0
- Sell transactions
- 2
- Companies
- 2
- Active
- 2025–2026
Across 5 filings between 2025–2026, Ho Carole, Director, has disclosed $112.4K in transactions — spread across 2 companies. Their disclosed trades are heavily weighted toward selling — $0 in buys and $51.7K in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| Jun 8 | RPRX Royalty Pharma plc | Ho Carole | Director | Grant | $0 |
| Aug 14 | DNLI Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | $51.7K |
| Aug 7 | DNLI Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Exercise | $60.7K |
| Jul 31 | RPRX Royalty Pharma plc | Ho Carole | Director | Grant | $0 |
| Jul 25 | RPRX Royalty Pharma plc | Ho Carole | Director | Other | $0 |
5 filings